日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Author Correction: DKN-01 and tislelizumab as second-line therapy in DKK1-high gastroesophageal adenocarcinoma: DisTinGuish trial part B

作者更正:DKN-01 和替雷利珠单抗作为 DKK1 高表达胃食管腺癌二线治疗:DisTinGuish 试验 B 部分

Lee, Keun-Wook; Mahalingam, Devalingam; Shim, Byoung Yong; Kim, In-Ho; Oh, Do-Youn; Uronis, Hope; Sym, Sun Jin; Sonbol, Mohamad; Almhanna, Khaldoun; Tejani, Mohamedtaki A; Kang, Beodeul; Kagey, Michael H; Stilian, Melissa; Jia, Calvin; Sirard, Cynthia A; Altura, Rachel; Ajani, Jaffer A; Klempner, Samuel J

Camonsertib, an ATRi, in Combination with Low-Dose Gemcitabine in Solid Tumors with DNA Damage Response Aberrations: Preclinical and Phase Ib Results

Camonsertib(一种ATRi)联合低剂量吉西他滨治疗伴有DNA损伤反应异常的实体瘤:临床前和Ib期研究结果

Rosen, Ezra Y; Yap, Timothy A; Fontana, Elisa; Lee, Elizabeth K; Mahalingam, Devalingam; Højgaard, Martin; Mettu, Niharika B; Cote, Gregory M; Plummer, Ruth; Koehler, Maria; Ulanet, Danielle; Fei, Kezhen; Silverman, Ian M; Schonhoft, Joseph D; Rimkunas, Victoria; Bacque, Emeline S; Gomez, Gabriela; Fretland, Adrian J; Roulston, Anne; Li, Li; Baruah, Prasamit; Zimmermann, Michal; Yang, Julia; Carneiro, Benedito A; Lheureux, Stephanie

First in human phase 1 study of DT2216, a selective BCL-xL degrader, in patients with relapsed/refractory solid malignancies

DT2216(一种选择性 BCL-xL 降解剂)在复发/难治性实体恶性肿瘤患者中的首次人体 I 期研究

Mahadevan, Daruka; Barve, Minal; Mahalingam, Devalingam; Parekh, Jay; Kurman, Michael; Strauss, James; Tremaine, Larry; Hromas, Robert; Sills, Joshua; McCulloch, John; Harkey, John; Suberg, Stacy; Zimmerman, Lisa; Zheng, Guangrong; Zhou, Daohong

DKN-01 and tislelizumab as second-line therapy in DKK1-high gastroesophageal adenocarcinoma: DisTinGuish trial part B

DKN-01 和替雷利珠单抗作为 DKK1 高表达胃食管腺癌的二线治疗:DisTinGuish 试验 B 部分

Lee, Keun-Wook; Mahalingam, Devalingam; Shim, Byoung Yong; Kim, In-Ho; Oh, Do-Youn; Uronis, Hope; Sym, Sun Jin; Sonbol, Mohamad; Almhanna, Khaldoun; Tejani, Mohamedtaki A; Kang, Beodeul; Kagey, Michael H; Stilian, Melissa; Jia, Calvin; Sirard, Cynthia A; Altura, Rachel; Ajani, Jaffer A; Klempner, Samuel J

TIMEPOINT, a phase 1 study combining MTL-CEBPA with pembrolizumab, supports the immunomodulatory effect of MTL-CEBPA in solid tumors

TIMEPOINT 是一项将 MTL-CEBPA 与帕博利珠单抗联合使用的 1 期研究,该研究支持 MTL-CEBPA 在实体瘤中的免疫调节作用。

Ruth Plummer ,Mikael H Sodergren ,Rose Hodgson ,Bríd M Ryan ,Nina Raulf ,Joanna P Nicholls ,Vikash Reebye ,Jon Voutila ,Laura Sinigaglia ,Tim Meyer ,David J Pinato ,Debashis Sarker ,Bristi Basu ,Sarah Blagden ,Natalie Cook ,Thomas R Jeffrey Evans ,Jeffrey Yachnin ,Cheng E Chee ,Daneng Li ,Anthony El-Khoueiry ,Maria Diab ,Kai-Wen Huang ,Madhava Pai ,Duncan Spalding ,Thomas Talbot ,Marcus S Noel ,Bridget Keenan ,Devalingam Mahalingam ,Min-Sun Song ,Mélanie Grosso ,Denis Arnaud ,Aurelie Auguste ,Dimitris Zacharoulis ,Jan Storkholm ,Iain McNeish ,Robert Habib ,John J Rossi ,Nagy A Habib

A trial of radiolabeled antibody yttrium-90-FF-21101 for the treatment of advanced ovarian and other cancers

一项使用放射性标记抗体钇-90-FF-21101治疗晚期卵巢癌和其他癌症的试验

Mahalingam, Devalingam; Owonikoko, Taofeek K; Delpassand, Ebrahim; Mulcahy, Mary F; Kalyan, Aparna; Ulahannan, Susanna; Cheung, Kin; Izumi, Yasayuki; Johansen, Mary; Madden, Timothy; Shimoyama, Susumu; Subach, Ruth Ann; Suzuki, Takeaki; Wages, David S; Wheeler, Catherine; Richardson, Debra L

Threading the Needle: Navigating Novel Immunotherapeutics in Pancreatic Ductal Adenocarcinoma

穿针引线:胰腺导管腺癌新型免疫疗法的应用

Demir, Tarik; Moloney, Carolyn; Mahalingam, Devalingam

Clinical and Molecular Differences Suggest Different Responses to Immune Checkpoint Inhibitors in Microsatellite-Stable Solid Tumors with High Tumor Mutational Burden

临床和分子差异表明,具有高肿瘤突变负荷的微卫星稳定型实体瘤对免疫检查点抑制剂的反应不同。

Nizamuddin, Imran; Demir, Tarik; Dobinda, Katrina; Chen, Ruohui; Kocherginsky, Masha; Doukas, Peter; Katam, Neelima; Moloney, Carolyn; Mahalingam, Devalingam

Phase II Study of Nivolumab and Ipilimumab for Treatment of Metastatic/Recurrent Adenoid Cystic Carcinoma (ACC) of all Anatomic Sites of Origin and Other Malignant Salivary Gland Tumors

纳武利尤单抗联合伊匹木单抗治疗转移性/复发性腺样囊性癌(ACC)(涵盖所有解剖部位)及其他恶性唾液腺肿瘤的II期研究

Chae, Young Kwang; Duan, Richard; Chung, Liam Il-Young; Oh, Youjin; Alexiev, Borislav; Shin, Sangwon; Kim, Sukjun; Helenowski, Irene; Matsangou, Maria; Villaflor, Victoria; Mahalingam, Devalingam

Delta Radiomics and Tumor Size: A New Predictive Radiomics Model for Chemotherapy Response in Liver Metastases from Breast and Colorectal Cancer

Delta放射组学与肿瘤大小:一种用于预测乳腺癌和结直肠癌肝转移化疗反应的新型放射组学模型

Gennaro, Nicolò; Soliman, Moataz; Borhani, Amir A; Kelahan, Linda; Savas, Hatice; Avery, Ryan; Subedi, Kamal; Trabzonlu, Tugce A; Krumpelman, Chase; Yaghmai, Vahid; Chae, Young; Lorch, Jochen; Mahalingam, Devalingam; Mulcahy, Mary; Benson, Al; Bagci, Ulas; Velichko, Yuri S